Index RUT
P/E -
EPS (ttm) -0.82
Insider Own 2.74%
Shs Outstand 244.92M
Perf Week 8.47%
Market Cap 472.78M
Forward P/E -
EPS next Y -0.64
Insider Trans 1.35%
Shs Float 239.50M
Perf Month 2.67%
Income -192.07M
PEG -
EPS next Q -0.18
Inst Own 77.27%
Short Float 9.78%
Perf Quarter -34.47%
Sales 2.31M
P/S 204.67
EPS this Y 10.81%
Inst Trans 18.05%
Short Ratio 5.41
Perf Half Y 90.10%
Book/sh 1.17
P/B 1.64
EPS next Y 9.77%
ROA -66.24%
Short Interest 23.44M
Perf Year -33.10%
Cash/sh 1.44
P/C 1.33
EPS next 5Y -
ROE -101.92%
52W Range 0.92 - 3.73
Perf YTD 25.49%
Dividend Est. -
P/FCF -
EPS past 5Y 6.80%
ROI -48.77%
52W High -48.53%
Beta 1.40
Dividend TTM -
Quick Ratio 15.56
Sales past 5Y 186.21%
Gross Margin 69.62%
52W Low 108.70%
ATR (14) 0.15
Dividend Ex-Date -
Current Ratio 15.58
EPS Y/Y TTM -30.42%
Oper. Margin -8045.91%
RSI (14) 54.91
Volatility 6.93% 8.52%
Employees 285
Debt/Eq 0.37
Sales Y/Y TTM 1734.13%
Profit Margin -8311.12%
Recom 1.80
Target Price 5.25
Option/Short Yes / Yes
LT Debt/Eq 0.36
EPS Q/Q -16.69%
Payout -
Rel Volume 0.38
Prev Close 1.87
Sales Surprise -21.43%
EPS Surprise -11.11%
Sales Q/Q 4608.33%
Earnings May 02 AMC
Avg Volume 4.33M
Price 1.92
SMA20 13.79%
SMA50 -5.01%
SMA200 15.05%
Trades
Volume 1,657,686
Change 2.67%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-30-24 Initiated
Leerink Partners
Outperform
$5
Mar-07-23 Initiated
Jefferies
Hold
$3
Aug-12-22 Initiated
Piper Sandler
Overweight
$10
Jan-29-21 Upgrade
JP Morgan
Underweight → Neutral
$7
Jan-29-21 Downgrade
Wedbush
Outperform → Neutral
$2 → $8
Dec-08-20 Upgrade
Citigroup
Neutral → Buy
Nov-18-20 Upgrade
Gabelli & Co
Hold → Buy
Dec-11-19 Downgrade
Gabelli & Co
Buy → Hold
Nov-08-19 Downgrade
Citigroup
Buy → Neutral
$3 → $4
Sep-11-19 Upgrade
Gabelli & Co
Hold → Buy
$3
Jul-29-19 Downgrade
Stifel
Buy → Hold
$10 → $4
Mar-25-19 Upgrade
Gabelli & Co
Sell → Hold
Jul-31-18 Reiterated
Stifel
Buy
$24 → $23
Feb-23-18 Downgrade
Needham
Buy → Hold
Feb-14-18 Downgrade
JP Morgan
Neutral → Underweight
$10
Mar-01-17 Reiterated
Wedbush
Outperform
$33 → $38
Mar-01-17 Reiterated
H.C. Wainwright
Buy
$26 → $27
Oct-07-16 Initiated
H.C. Wainwright
Buy
$26
Aug-05-16 Reiterated
Wedbush
Outperform
$30 → $31
Aug-02-16 Initiated
Citigroup
Buy
$21
Show Previous Ratings
Today 08:03AM
07:00AM
May-09-24 07:30AM
May-06-24 10:05AM
May-03-24 07:46AM
(Thomson Reuters StreetEvents)
04:07AM
Loading…
04:07AM
May-02-24 08:59PM
06:05PM
06:03PM
05:00PM
(Associated Press Finance)
04:05PM
Apr-29-24 10:42AM
09:00AM
07:00AM
Apr-18-24 08:00AM
12:00PM
Loading…
Apr-16-24 12:00PM
Apr-03-24 08:00AM
Mar-25-24 09:20AM
Mar-13-24 12:45PM
Mar-12-24 08:00AM
Mar-11-24 08:25AM
07:34AM
(Associated Press Finance)
07:15AM
07:05AM
07:00AM
Feb-29-24 10:00AM
Feb-22-24 12:58PM
Jan-31-24 05:06AM
Jan-23-24 05:21AM
Jan-08-24 07:00AM
05:06AM
Loading…
Dec-26-23 05:06AM
Dec-21-23 04:15PM
Nov-30-23 07:30AM
Nov-22-23 07:30AM
Nov-15-23 01:03AM
Nov-12-23 02:10PM
Nov-10-23 04:01PM
10:53AM
Nov-08-23 09:45PM
(Thomson Reuters StreetEvents) -8.80%
07:19AM
(Associated Press Finance)
07:00AM
Nov-03-23 09:00AM
Nov-02-23 09:00AM
Nov-01-23 09:00AM
Oct-31-23 04:01PM
Oct-30-23 04:01PM
Oct-25-23 08:45AM
Oct-17-23 04:01PM
01:35PM
Oct-13-23 11:38AM
Oct-11-23 11:13AM
09:00AM
Oct-10-23 11:25AM
09:44AM
03:33AM
Oct-09-23 04:01PM
08:00AM
Sep-28-23 09:00AM
Sep-26-23 09:00AM
Sep-20-23 12:28PM
Sep-14-23 09:40PM
Sep-07-23 04:30PM
09:00AM
Aug-21-23 09:00AM
Aug-17-23 09:56AM
Aug-08-23 09:00AM
Aug-04-23 09:12AM
Aug-03-23 05:15PM
04:10PM
04:01PM
Jul-28-23 04:01PM
08:00AM
Jun-30-23 06:52AM
Jun-27-23 06:46AM
Jun-23-23 08:45PM
09:24AM
Jun-20-23 08:00AM
Jun-15-23 05:00PM
Jun-06-23 04:01PM
Jun-05-23 04:01PM
Jun-04-23 07:00AM
Jun-02-23 09:21AM
Jun-01-23 11:35AM
08:00AM
May-31-23 04:01PM
May-26-23 04:25PM
04:08PM
04:05PM
May-22-23 07:33AM
May-11-23 06:50AM
May-10-23 04:30PM
May-04-23 10:05AM
May-03-23 11:45AM
(Thomson Reuters StreetEvents) +15.13%
May-02-23 04:00PM
Apr-28-23 04:00PM
Apr-22-23 08:15AM
Apr-21-23 09:00AM
Apr-17-23 04:00PM
Mar-06-23 06:00AM
Mar-04-23 12:00PM
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SOBECKI CHRISTOPHER J Director Apr 28 '24 Option Exercise 0.00 8,032 0 167,055 Apr 29 04:20 PM Swain Judith L Director Apr 28 '24 Option Exercise 0.00 8,032 0 48,364 Apr 29 04:21 PM DEBBANE RAYMOND Director Apr 28 '24 Option Exercise 0.00 8,032 0 1,348,879 Apr 29 04:17 PM LEFKOWITZ ROBERT J MD Director Apr 28 '24 Option Exercise 0.00 8,032 0 48,364 Apr 29 04:18 PM BARKER SAM L Director Apr 28 '24 Option Exercise 0.00 8,032 0 87,649 Apr 29 04:17 PM Amouyal Philippe Director Apr 28 '24 Option Exercise 0.00 8,032 0 248,364 Apr 29 04:16 PM COATS LONNEL Chief Executive Officer Nov 16 '23 Buy 1.05 90,000 94,797 914,359 Nov 17 04:55 PM COATS LONNEL Chief Executive Officer Nov 10 '23 Buy 1.01 10,000 10,100 824,359 Nov 13 05:31 PM DEBBANE RAYMOND Director Oct 12 '23 Buy 1.03 148,820 153,805 1,340,847 Oct 12 04:01 PM DEBBANE RAYMOND Director Oct 11 '23 Buy 1.08 342,874 370,784 1,192,027 Oct 12 04:01 PM DEBBANE RAYMOND Director Oct 10 '23 Buy 1.14 508,306 579,367 849,153 Oct 12 04:01 PM WADE JEFFREY L President and CFO Sep 14 '23 Buy 1.38 10,000 13,800 264,341 Sep 14 05:05 PM McDermott Wendy VP, Human Resources Aug 04 '23 Buy 1.84 6,000 11,040 28,478 Aug 07 04:13 PM COATS LONNEL Chief Executive Officer Jun 29 '23 Buy 2.16 10,000 21,600 814,359 Jun 29 04:13 PM COATS LONNEL Chief Executive Officer Jun 26 '23 Buy 2.18 10,000 21,792 804,359 Jun 26 04:04 PM COATS LONNEL Chief Executive Officer Jun 23 '23 Buy 2.50 10,000 24,950 794,359 Jun 26 04:04 PM McDermott Wendy VP, Human Resources Jun 23 '23 Buy 2.43 10,000 24,300 22,478 Jun 27 04:22 PM COATS LONNEL Chief Executive Officer Jun 22 '23 Buy 2.31 40,000 92,400 784,359 Jun 22 04:01 PM WADE JEFFREY L President and CFO Jun 20 '23 Buy 2.33 12,000 28,000 254,341 Jun 20 04:10 PM Artal International S.C.A. Director Jun 05 '23 Buy 2.60 27,775,050 72,215,130 78,634,381 Jun 05 04:46 PM Swain Judith L Director May 21 '23 Option Exercise 0.00 9,302 0 40,332 May 22 04:07 PM NIES ALAN S Director May 21 '23 Option Exercise 0.00 9,302 0 41,046 May 22 04:05 PM DEBBANE RAYMOND Director May 21 '23 Option Exercise 0.00 9,302 0 340,847 May 22 04:03 PM LEFKOWITZ ROBERT J MD Director May 21 '23 Option Exercise 0.00 9,302 0 40,332 May 22 04:04 PM Palantoni Frank Director May 21 '23 Option Exercise 0.00 9,302 0 40,332 May 22 04:06 PM SOBECKI CHRISTOPHER J Director May 21 '23 Option Exercise 0.00 9,302 0 159,023 May 22 04:06 PM Amouyal Philippe Director May 21 '23 Option Exercise 0.00 9,302 0 40,332 May 22 04:01 PM BARKER SAM L Director May 21 '23 Option Exercise 0.00 9,302 0 79,617 May 22 04:02 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite